close
share

Main information

Fund name Leadersel Innotech Class R
Benchmark 100% MSCI World Index
Category International equity fund
Legal structure Luxembourg umbrella mutual fund
Currency Euro

Investment policy

The Sub Fund Manager uses scientific and industrial analysis to identify companies developing innovative products and services that are more likely to disrupt a sector or change people habits and behaviors. Once identified, the Manager uses fundamental analysis to  select long and short investments mainly in equity; both equity securities and ETD or OTC derivatives (equity swap). The Fund integrates ESG (environmental, social, governance) criteria in the investment process, alongside financial criteria managed from a risk-return perspective. Material ESG issues are addressed and promoted through active ownership. A positive ESG screening is performed on individual instruments at the time of their acquisition. In addition, certain sectors, companies, products, or activities are restricted from the investment universe. In order to realize its investment strategy, the Fund will invest mainly in different classes of international transferable securities, mainly equities and derivatives on equities, and, on a residual basis, in bonds, money market instruments and other derivatives. In particular, the Fund will use listed derivatives (such as, for example, futures and options) and OTC derivatives (such as, for example, Contracts for Difference, Equity Swap or Total Return Swap) in order to realize the investment strategy of the Fund and to create long and short exposure. The underlying assets of the Total Return Swaps will mainly be equities. The Fund may also invest in ADR (American Depositary Receipts) or GDR (Global Depositary Receipt) on a tactical basis. Those ADR/GDR will not have derivative incorporated products. All bonds will be investment grade. In terms of geographical exposure, the Fund will invest mainly in developed markets (such as markets in countries belonging to the EU and the OECD).The balance may be invested in any instrument listed in the above paragraph, including emerging markets instruments. In such case, the Fund will invest only in securities listed on regulated markets. The Fund may hold cash, up to 10% of its net assets with the same credit institution and up to 20% with the Depositary Bank. The Fund may invest up to ten per cent (10%) of its net assets in UCITS or other UCI as referred to in art. 41, section 1, of the Law of 2010. The Fund may not invest more than 20% of its net assets in equities issued by companies listed in Hong Kong and Mainland China, including H shares, A shares and B shares, taking into account the risks associated with such investments described in the “Fund Investment Objectives and Policy”chapter of the prospectus. The Fund may use financial techniques and instruments in order to promote an efficient portfolio management, in accordance with the restrictions set forth in the “Financial techniques and instruments” chapter of the prospectus.

Investment object

This Fund is actively managed and seeks to grow capital and to generate income. The Fund has no reference Benchmark. The investment objective of this Fund is to achieve maximum capital appreciation commensurate with reasonable risk.

Legal information

Depository bank Caceis Bank, Luxembourg branch
Audit firm EY
How to subscribe it

The Funds managed by Ersel Gestion Internationale S.A. can be subscribed by sending an order to the Transfer Agent and Custodian Bank of the Fund. Investor Services Team:

  • Email address: fds-investor-services@caceis.com
  • Phone number: 00 352 47 6759 99
  • Fax number: 00 352 47 67 70 37
  • Business hours: 9 a.m. to 6 p.m. CET
  • Languages: Inglese, French, Spanish, Italian, German, Dutch

For institutional investors the orders can also be transmitted through the following distributors: Allfunds Bank, Mfex, Fund Channel.

NAV calculation frequency Daily
Fund units publication Fundsquare.net

Fund ticker

ISIN code LU2232027305
Bloomberg LLIEREA LX

Charges

Entry charge None
Exit charge None
Maximum management fees 1.5% on an annual basis
Performance fee 20% calculated on the positive difference between the net return of the Fund and the index consisting of 10% ICE BofA Euro Treasury Bill Index and 90% MSCI World net TR Index in the reference year.
Minimum amount of the first subscription 2.500 euro
Minimum amount of subsequent subscriptions None

Performance

Period NAV Fund Benchmark
- - - -
* Average annual compound yield
NOTE: Before subscribing, read the informative prospectus. There is no guarantee of obtaining the same return afterwards.

Graphic trend

Summary table

1 year 3 years 5 years 10 years
Fund - - - -
Benchmark - - - -
1 year 3 years 5 years 10 years
Fund - - - -
Benchmark - - - -
1 year 3 years 5 years 10 years
Fund - - - -
Benchmark - - - -

Annual chart

May marked a significant rebound for the fund, supported by a combination of strong corporate results, renewed enthusiasm for technological innovation, and signs of economic resilience in key investment sectors.

Monthly comment from the manager

In a still-uncertain macroeconomic environment, markets rewarded the most innovative business models and companies capable of demonstrating sustainable growth and adaptability. Despite recent restrictive proposals emerging from the US House Rules Committee regarding the 45Y (PTC) and 48E (ITC) tax credits, the Cleantech sector showed resilience thanks to a strong pipeline of already-qualified projects and the growing commitment of operators to meet new regulatory requirements. The digital sector was the main driver of monthly performance.

Snowflake delivered a positive surprise, with a 26% year-on-year increase in product revenue, solid customer base expansion, and a strong sales pipeline. MongoDB, Datadog, and Zscaler benefited from growing interest in agentic AI and advanced automation, with numerous new enterprise-level pilot projects. The development of AI infrastructure and the increasing demand for distributed inference continue to support momentum for companies such as Broadcom, Alphawave, and Ambarella.

The Healthtech segment benefited from heightened attention to computational biotechnology and precision medicine. AbCellera and Schrödinger reported progress in their pipelines, while Recursion Pharmaceuticals strengthened its partnerships with strategic players for the development of AI-driven solutions. Guardant Health released encouraging updates on new devices and diagnostic tests, receiving a positive response from the market. A favourable regulatory environment and the growing relevance of medtech innovation continue to support the sector’s performance.

Offer documents

Document Date of the document Download
KID 15/04/2025 PDF get_app
Management rules 05/02/2019 PDF get_app
Prospectus 15/04/2025 PDF get_app

Semi-annual reports

Document Date of the document Download
Semi annual report 30/06/2024 PDF get_app
Semi annual report CH 30/06/2024 PDF get_app

Annual reports

Document Date of the document Download
Annual report 31/12/2024 PDF get_app
Annual Report CH 31/12/2023 PDF get_app

Art. 8 Policy

Document Date of the document Download
Responsible Investment Policy 04/06/2025 PDF get_app

Art. 8 Related disclosure

Document Date of the document Download
Web Disclosure 04/06/2025 PDF get_app
Leadersel Innotech - Pre-contractual disclosure information RTS 15/04/2025 PDF get_app
Leadersel Innotech - Periodic Disclosure RTS 15/05/2025 PDF get_app

Notice

Document Date of the document Download
Notice to unitholders 16/05/2024 PDF get_app
Investors' Notice 30/06/2023 PDF get_app
Fund manager
Marco Gennari
Team Investimenti Tecnologia ESG
Risk level
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
Rating
CFS Rating star star star star star

RISPARMIO ENERGETICO ATTIVO

Questa schermata consente al tuo monitor di consumare meno energia quando il computer resta inattivo.

Clicca in qualsiasi parte dello schermo per riprendere la navigazione.